Terms: = Head and neck cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Treatment
62 results:
1. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Song Y; Jin Z; Li ZM; Liu Y; Li L; He C; Su H; Zhou H; Li K; Hao S; Zuo X; Wu J; Li D; Wu M; Sun X; Qi J; Cai Z; Li Z; Li Y; Huang Y; Shen J; Xiao Z; Zhu J
Clin Cancer Res; 2024 Apr; 30(7):1248-1255. PubMed ID: 38190117
[TBL] [Abstract] [Full Text] [Related]
2. Drug-induced inhibition of HMGA and ezh2 activity as a possible therapy for anaplastic thyroid carcinoma.
De Martino M; Pellecchia S; Decaussin-Petrucci M; Testa D; Meireles Da Costa N; Pallante P; Chieffi P; Fusco A; Esposito F
Cell Cycle; 2023; 22(23-24):2552-2565. PubMed ID: 38165007
[TBL] [Abstract] [Full Text] [Related]
3. Enhancer of zeste homolog 2 (ezh2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.
Chang HW; Park JJ; Lee WH; Kim SH; Lee JC; Nam HY; Kim MR; Han MW; Lee YS; Kim SY; Kim SW
Cell Signal; 2024 Mar; 115():111029. PubMed ID: 38163576
[TBL] [Abstract] [Full Text] [Related]
4. Brucea javanica oil inhibits tongue squamous cell invasion and metastasis by regulating miR-138-ezh2 pathway.
Jiang L; Zhou J; Wu Y; Zhou L; Zhang C; Zhu J; Fang Z; Shao Y; Wang W
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101611. PubMed ID: 37619672
[TBL] [Abstract] [Full Text] [Related]
5. Modulation of ezh2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid cancer.
de Mello DC; Saito KC; Cristovão MM; Kimura ET; Fuziwara CS
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175580
[TBL] [Abstract] [Full Text] [Related]
6. Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via ezh2/STAT pathway.
Tan R; Liu J; Wang J; Zhang W; He M; Zhang Y
Sci Rep; 2023 Apr; 13(1):5363. PubMed ID: 37005451
[TBL] [Abstract] [Full Text] [Related]
7. Validation of ezh2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell Lines.
Nakayama H; Saito N; Kasajima R; Suganuma N; Rino Y; Masudo K; Yamazaki H; Toda S; Sekihara K; Iwasaki H; Hoshino D
Anticancer Res; 2023 Mar; 43(3):1073-1077. PubMed ID: 36854530
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of ezh2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
11. ezh2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas.
Nourmohammadi F; Forghanifard MM; Abbaszadegan MR; Zarrinpour V
Sci Rep; 2022 Oct; 12(1):18290. PubMed ID: 36316365
[TBL] [Abstract] [Full Text] [Related]
12. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
Gupta AK; Kumar M
Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of intrafraction couch shifts for proton treatment delivery in head-and-neck cancer patients: Toward optimal imaging frequency.
Biswal NC; Rodrigues DB; Yao W; Molitoris JK; Witek ME; Chen S
J Appl Clin Med Phys; 2022 Dec; 23(12):e13795. PubMed ID: 36239306
[TBL] [Abstract] [Full Text] [Related]
14. EBF3 reactivation by inhibiting the EGR1/ezh2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma.
Ding S; Wang X; Lv D; Tao Y; Liu S; Chen C; Huang Z; Zheng S; Wei Y; Kang T; Xia Y
Cancer Lett; 2022 Feb; 527():49-65. PubMed ID: 34906623
[TBL] [Abstract] [Full Text] [Related]
15. Long noncoding RNA SNHG6 promotes oesophageal squamous cell carcinoma by downregulating the miR-101-3p/ezh2 pathway.
Zhang Y; Li R; Ding X; He M; Zhang R
J Biochem Mol Toxicol; 2022 Feb; 36(2):e22959. PubMed ID: 34766670
[TBL] [Abstract] [Full Text] [Related]
16. Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated ezh2 stabilization.
Wu T; Wang G; Zeng X; Sun Z; Li S; Wang W; Yu B
Cell Cycle; 2021 Sep; 20(18):1799-1811. PubMed ID: 34437823
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
[No Abstract] [Full Text] [Related]
18. Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma.
Xu X; Chen J; Li Y; Yang X; Wang Q; Wen Y; Yan M; Zhang J; Xu Q; Wei Y; Chen W; Wang X
Cell Death Dis; 2021 May; 12(5):482. PubMed ID: 33986254
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a RNA binding protein-associated prognostic model for head and neck squamous cell carcinoma.
Yang X; Han B; Zhang R; Su Y; Hosseini DK; Wu H; Yang M; Sun H
Aging (Albany NY); 2021 Mar; 13(6):7975-7997. PubMed ID: 33758106
[TBL] [Abstract] [Full Text] [Related]
20. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-ezh2 signalling pathway.
Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
[TBL] [Abstract] [Full Text] [Related]
[Next]
